Eli Lilly is building a highly automated plant for injectable medicines and pen devices in Alzey, with an investment of around EUR 2.3 billion. The site is planned to create about 1,000 permanent jobs and to start operating by the end of 2027.
- Stage
- Under construction
- Client / owner
- Eli Lilly and Company
- Main contractors
- THOST (project management)

